345 related articles for article (PubMed ID: 23372686)
21. The transcriptional regulators TAZ and YAP direct transforming growth factor β-induced tumorigenic phenotypes in breast cancer cells.
Hiemer SE; Szymaniak AD; Varelas X
J Biol Chem; 2014 May; 289(19):13461-74. PubMed ID: 24648515
[TBL] [Abstract][Full Text] [Related]
22. Axl Is a Potential Cancer Prognostic Marker for the Migration and Invasion of Nasopharyngeal Carcinoma.
Jiang C; Zhou L; Wang H; Zhang Q; Xu Y
Adv Clin Exp Med; 2016; 25(3):531-7. PubMed ID: 27629742
[TBL] [Abstract][Full Text] [Related]
23. Axl kinase drives immune checkpoint and chemokine signalling pathways in lung adenocarcinomas.
Tsukita Y; Fujino N; Miyauchi E; Saito R; Fujishima F; Itakura K; Kyogoku Y; Okutomo K; Yamada M; Okazaki T; Sugiura H; Inoue A; Okada Y; Ichinose M
Mol Cancer; 2019 Feb; 18(1):24. PubMed ID: 30744655
[TBL] [Abstract][Full Text] [Related]
24. Deregulation of Hippo-TAZ pathway during renal injury confers a fibrotic maladaptive phenotype.
Anorga S; Overstreet JM; Falke LL; Tang J; Goldschmeding RG; Higgins PJ; Samarakoon R
FASEB J; 2018 May; 32(5):2644-2657. PubMed ID: 29298862
[TBL] [Abstract][Full Text] [Related]
25. Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-smallcell Lung Cancer Associated With Poor Prognosis.
Karachaliou N; Chaib I; Cardona AF; Berenguer J; Bracht JWP; Yang J; Cai X; Wang Z; Hu C; Drozdowskyj A; Servat CC; Servat JC; Ito M; Attili I; Aldeguer E; Capitan AG; Rodriguez J; Rojas L; Viteri S; Molina-Vila MA; Ou SI; Okada M; Mok TS; Bivona TG; Ono M; Cui J; Ramón Y Cajal S; Frias A; Cao P; Rosell R
EBioMedicine; 2018 Mar; 29():112-127. PubMed ID: 29433983
[TBL] [Abstract][Full Text] [Related]
26. LncRNA XIST modulates HIF-1A/AXL signaling pathway by inhibiting miR-93-5p in colorectal cancer.
Yang LG; Cao MZ; Zhang J; Li XY; Sun QL
Mol Genet Genomic Med; 2020 Apr; 8(4):e1112. PubMed ID: 32061057
[TBL] [Abstract][Full Text] [Related]
27. The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer.
Uribe DJ; Mandell EK; Watson A; Martinez JD; Leighton JA; Ghosh S; Rothlin CV
PLoS One; 2017; 12(7):e0179979. PubMed ID: 28727830
[TBL] [Abstract][Full Text] [Related]
28. The receptor tyrosine kinase Axl is an essential regulator of prostate cancer proliferation and tumor growth and represents a new therapeutic target.
Paccez JD; Vasques GJ; Correa RG; Vasconcellos JF; Duncan K; Gu X; Bhasin M; Libermann TA; Zerbini LF
Oncogene; 2013 Feb; 32(6):689-98. PubMed ID: 22410775
[TBL] [Abstract][Full Text] [Related]
29. Role of AXL in invasion and drug resistance of colon and breast cancer cells and its association with p53 alterations.
Abdel-Rahman WM; Al-Khayyal NA; Nair VA; Aravind SR; Saber-Ayad M
World J Gastroenterol; 2017 May; 23(19):3440-3448. PubMed ID: 28596680
[TBL] [Abstract][Full Text] [Related]
30. Regulation of cellular quiescence by YAP/TAZ and Cyclin E1 in colon cancer cells: Implication in chemoresistance and cancer relapse.
Corvaisier M; Bauzone M; Corfiotti F; Renaud F; El Amrani M; Monté D; Truant S; Leteurtre E; Formstecher P; Van Seuningen I; Gespach C; Huet G
Oncotarget; 2016 Aug; 7(35):56699-56712. PubMed ID: 27527859
[TBL] [Abstract][Full Text] [Related]
31. Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA.
Mackiewicz M; Huppi K; Pitt JJ; Dorsey TH; Ambs S; Caplen NJ
Breast Cancer Res Treat; 2011 Nov; 130(2):663-79. PubMed ID: 21814748
[TBL] [Abstract][Full Text] [Related]
32. TAZ target gene ITGAV regulates invasion and feeds back positively on YAP and TAZ in liver cancer cells.
Weiler SME; Lutz T; Bissinger M; Sticht C; Knaub M; Gretz N; Schirmacher P; Breuhahn K
Cancer Lett; 2020 Mar; 473():164-175. PubMed ID: 31904487
[TBL] [Abstract][Full Text] [Related]
33. AXL is an oncotarget in human colorectal cancer.
Martinelli E; Martini G; Cardone C; Troiani T; Liguori G; Vitagliano D; Napolitano S; Morgillo F; Rinaldi B; Melillo RM; Liotti F; Nappi A; Bianco R; Berrino L; Ciuffreda LP; Ciardiello D; Iaffaioli V; Botti G; Ferraiolo F; Ciardiello F
Oncotarget; 2015 Sep; 6(27):23281-96. PubMed ID: 25966280
[TBL] [Abstract][Full Text] [Related]
34. Cbx7 is epigenetically silenced in glioblastoma and inhibits cell migration by targeting YAP/TAZ-dependent transcription.
Nawaz Z; Patil V; Arora A; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
Sci Rep; 2016 Jun; 6():27753. PubMed ID: 27291091
[TBL] [Abstract][Full Text] [Related]
35. The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma.
Hector A; Montgomery EA; Karikari C; Canto M; Dunbar KB; Wang JS; Feldmann G; Hong SM; Haffner MC; Meeker AK; Holland SJ; Yu J; Heckrodt TJ; Zhang J; Ding P; Goff D; Singh R; Roa JC; Marimuthu A; Riggins GJ; Eshleman JR; Nelkin BD; Pandey A; Maitra A
Cancer Biol Ther; 2010 Nov; 10(10):1009-18. PubMed ID: 20818175
[TBL] [Abstract][Full Text] [Related]
36. Yes-associated protein 1 (YAP1) promotes human gallbladder tumor growth via activation of the AXL/MAPK pathway.
Li M; Lu J; Zhang F; Li H; Zhang B; Wu X; Tan Z; Zhang L; Gao G; Mu J; Shu Y; Bao R; Ding Q; Wu W; Dong P; Gu J; Liu Y
Cancer Lett; 2014 Dec; 355(2):201-9. PubMed ID: 25218593
[TBL] [Abstract][Full Text] [Related]
37. ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer.
Liu CY; Yu T; Huang Y; Cui L; Hong W
J Biol Chem; 2017 Jun; 292(22):9420-9430. PubMed ID: 28408625
[TBL] [Abstract][Full Text] [Related]
38. Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.
Noto A; De Vitis C; Pisanu ME; Roscilli G; Ricci G; Catizone A; Sorrentino G; Chianese G; Taglialatela-Scafati O; Trisciuoglio D; Del Bufalo D; Di Martile M; Di Napoli A; Ruco L; Costantini S; Jakopin Z; Budillon A; Melino G; Del Sal G; Ciliberto G; Mancini R
Oncogene; 2017 Aug; 36(32):4573-4584. PubMed ID: 28368399
[TBL] [Abstract][Full Text] [Related]
39. Negative feedback regulation of AXL by miR-34a modulates apoptosis in lung cancer cells.
Cho CY; Huang JS; Shiah SG; Chung SY; Lay JD; Yang YY; Lai GM; Cheng AL; Chen LT; Chuang SE
RNA; 2016 Feb; 22(2):303-15. PubMed ID: 26667302
[TBL] [Abstract][Full Text] [Related]
40. Hypoxia stabilizes GAS6/Axl signaling in metastatic prostate cancer.
Mishra A; Wang J; Shiozawa Y; McGee S; Kim J; Jung Y; Joseph J; Berry JE; Havens A; Pienta KJ; Taichman RS
Mol Cancer Res; 2012 Jun; 10(6):703-12. PubMed ID: 22516347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
